Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

276 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Overexpression of the opioid growth factor receptor potentiates growth inhibition in human pancreatic cancer cells.
Zagon IS, Verderame MF, Hankins J, McLaughlin PJ. Zagon IS, et al. Among authors: hankins j. Int J Oncol. 2007 Apr;30(4):775-83. Int J Oncol. 2007. PMID: 17332915
Overexpression of the opioid growth factor receptor downregulates cell proliferation of human squamous carcinoma cells of the head and neck.
McLaughlin PJ, Verderame MF, Hankins JL, Zagon IS. McLaughlin PJ, et al. Among authors: hankins jl. Int J Mol Med. 2007 Mar;19(3):421-8. Int J Mol Med. 2007. PMID: 17273790
Exogenous ceramide-1-phosphate reduces lipopolysaccharide (LPS)-mediated cytokine expression.
Hankins JL, Fox TE, Barth BM, Unrath KA, Kester M. Hankins JL, et al. J Biol Chem. 2011 Dec 30;286(52):44357-66. doi: 10.1074/jbc.M111.264010. Epub 2011 Nov 7. J Biol Chem. 2011. PMID: 22065582 Free PMC article.
Ceramide 1-phosphate mediates endothelial cell invasion via the annexin a2-p11 heterotetrameric protein complex.
Hankins JL, Ward KE, Linton SS, Barth BM, Stahelin RV, Fox TE, Kester M. Hankins JL, et al. J Biol Chem. 2013 Jul 5;288(27):19726-38. doi: 10.1074/jbc.M113.481622. Epub 2013 May 21. J Biol Chem. 2013. PMID: 23696646 Free PMC article.
The therapeutic potential of nanoscale sphingolipid technologies.
Hankins JL, Doshi UA, Haakenson JK, Young MM, Barth BM, Kester M. Hankins JL, et al. Handb Exp Pharmacol. 2013;(215):197-210. doi: 10.1007/978-3-7091-1368-4_11. Handb Exp Pharmacol. 2013. PMID: 23579457 Review.
Ceramide kinase regulates TNFα-stimulated NADPH oxidase activity and eicosanoid biosynthesis in neuroblastoma cells.
Barth BM, Gustafson SJ, Hankins JL, Kaiser JM, Haakenson JK, Kester M, Kuhn TB. Barth BM, et al. Among authors: hankins jl. Cell Signal. 2012 Jun;24(6):1126-33. doi: 10.1016/j.cellsig.2011.12.020. Epub 2011 Dec 30. Cell Signal. 2012. PMID: 22230689 Free PMC article.
Initial Guidance on Use of Monoclonal Antibody Therapy for Treatment of COVID-19 in Children and Adolescents.
Wolf J, Abzug MJ, Wattier RL, Sue PK, Vora SB, Zachariah P, Dulek DE, Waghmare A, Olivero R, Downes KJ, James SH, Pinninti SG, Yarbrough A, Aldrich ML, MacBrayne CE, Soma VL, Grapentine SP, Oliveira CR, Hayes M, Kimberlin DW, Jones SB, Bio LL, Morton TH, Hankins JS, Marόn-Alfaro GM, Timberlake K, Young JL, Orscheln RC, Schwenk HT, Goldman DL, Groves HE, Huskins WC, Rajapakse NS, Lamb GS, Tribble AC, Lloyd EE, Hersh AL, Thorell EA, Ratner AJ, Chiotos K, Nakamura MM. Wolf J, et al. Among authors: hankins js. J Pediatric Infect Dis Soc. 2021 Jan 3:piaa175. doi: 10.1093/jpids/piaa175. Online ahead of print. J Pediatric Infect Dis Soc. 2021. PMID: 33388760
Genetic variants associated with therapy-related cardiomyopathy among childhood cancer survivors of African ancestry.
Sapkota Y, Qin N, Ehrhardt MJ, Wang Z, Chen Y, Wilson CL, Estepp J, Rai P, Hankins JS, Burridge PW, Jefferies JL, Zhang J, Hudson MM, Robison LL, Armstrong GT, Mulrooney DA, Yasui Y. Sapkota Y, et al. Among authors: hankins js. Cancer Res. 2020 Dec 7:canres.2675.2020. doi: 10.1158/0008-5472.CAN-20-2675. Online ahead of print. Cancer Res. 2020. PMID: 33288658
Empirically Derived Profiles of Health-Related Quality of Life in Youth and Young Adults with Sickle Cell Disease.
Keenan ME, Loew M, Berlin KS, Hodges J, Alberts NM, Hankins JS, Porter JS. Keenan ME, et al. Among authors: hankins js. J Pediatr Psychol. 2020 Nov 29:jsaa104. doi: 10.1093/jpepsy/jsaa104. Online ahead of print. J Pediatr Psychol. 2020. PMID: 33249456
Use of Wise Device Technology to Measure Adherence to Hydroxyurea Therapy in Youth With Sickle Cell Disease.
Ingerski LM, Loew M, Porter JS, Su Y, Zhang H, Hankins JS, Wang WC. Ingerski LM, et al. Among authors: hankins js. J Pediatr Hematol Oncol. 2021 Jan;43(1):e19-e25. doi: 10.1097/MPH.0000000000001997. J Pediatr Hematol Oncol. 2021. PMID: 33235145
276 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback